31 studies found for:    FAMILIAL ADENOMATOUS POLYPOSIS 1
Show Display Options
Rank Status Study
1 Completed Chemoprevention Trial in Familial Adenomatous Polyposis Coli Using EPA
Conditions: Familial Adenomatous Polyposis Coli;   FAP
Interventions: Drug: Eicosapentanoic Acid (EPA);   Procedure: Endoscopy;   Procedure: Biopsies taken;   Procedure: Clinical Chemistry;   Procedure: Haematology;   Procedure: Physical examination;   Procedure: Vital signs;   Procedure: Urine pregnancy test;   Procedure: Completion of patient diary card;   Procedure: Peripheral blood sample
2 Recruiting A Clinical Trial of COX and EGFR Inhibition in Familial Polyposis Patients
Condition: Adenomatous Polyposis Coli
Interventions: Drug: Erlotinib;   Drug: Sulindac;   Drug: Placebo A;   Drug: Placebo B
3 Recruiting Molecular Fluorescence Endoscopy in Patients With Familial Adenomatous Polyposis, Using Bevacizumab-IRDye800CW
Condition: Adenomatous Polyposis Coli
Interventions: Drug: Bevacizumab-IRDye800CW;   Device: Near infrared fluorescence endoscopy platform
4 Unknown  Influence of Sulindac and Probiotics on the Development of Pouch Adenomas in Patients With Familial Adenomatous Polyposis
Condition: Adenomatous Polyposis Coli
Interventions: Drug: Sulindac (drug);   Drug: VSL#3 (probiotic);   Drug: Inulin (probiotic)
5 Terminated Trial In Pediatric Patients With Familial Adenomatous Polyposis (FAP)
Condition: Adenomatous Polyposis Coli
Interventions: Drug: Celecoxib;   Drug: Placebo
6 Recruiting Registry With Information About Colitis Ulcerosa and Familial Adenomatous Polyposis Patients
Conditions: Colitis,Ulcerative;   Adenomatous Polyposis Coli;   Reservoir, Ileoanal
Intervention:
7 Terminated A Study of Rofecoxib in Familial Adenomatous Polyposis (FAP)
Condition: Adenomatous Polyposis Coli
Interventions: Drug: MK0966; rofecoxib / Duration of Treatment: 24 weeks;   Drug: Comparator: placebo / Duration of Treatment: 24 weeks
8 Unknown  Ursodeoxycholic Acid in the Treatment of Duodenal Adenomas in Familial Adenomatous Polyposis (FAP) Patients
Condition: Adenomatous Polyposis Coli, Familial
Interventions: Drug: Ursodeoxycholic acid;   Drug: Placebo
9 Completed Celecoxib With or Without Eflornithine in Preventing Colorectal Cancer in Patients With Familial Adenomatous Polyposis
Conditions: Colorectal Cancer;   Familial Adenomatous Polyposis
Interventions: Drug: celecoxib;   Other: placebo;   Drug: eflornithine;   Other: laboratory biomarker analysis;   Other: questionnaire administration
10 Completed A Cohort Study of Patients Treated With Brachytherapy for Selected Desmoid Patients in Gardner Syndrome
Conditions: Gardner Syndrome;   Colorectal Carcinoma;   Desmoid Tumor
Intervention:
11 Active, not recruiting Molecular Targeting of 15-Lipoxygenase-1 (15-LOX-1) for Apoptosis Induction in Human Colorectal Cancers
Condition: Familial Adenomatous Polyposis
Interventions: Drug: Celecoxib;   Procedure: Colonoscopy Biopsy
12 Completed Prevention of Progression of Duodenal Adenomas in Patients With Familial Adenomatous Polyposis
Conditions: Familial Adenomatous Polyposis;   Duodenal Neoplasms;   Duodenal Polyps
Interventions: Drug: Celecoxib;   Drug: Ursodeoxycholic acid;   Drug: Placebo
13 Unknown  Adenoma Detection Rate:NBI, AFI, Chromoscopic or Standard Endoscopy
Condition: Familial Adenomatous Polyposis
Intervention: Procedure: flexible sigmoidoscopy
14 Withdrawn A Trial of Low Dose Sulindac Combined With Eflornithine in Patients With Familial Adenomatous Polyposis (FAP)
Condition: Familial Adenomatous Polyposis
Interventions: Drug: Eflornithine plus Sulindac;   Drug: Eflornithine plus Placebo;   Drug: Sulindac plus Placebo
15 Terminated Coxib-inhibition of Duodenal Polyp Growth in FAP
Condition: Duodenal Polyposis
Interventions: Drug: Rofecoxib;   Drug: placebo
16 Recruiting Trial of Eflornithine Plus Sulindac in Patients With Familial Adenomatous Polyposis (FAP)
Condition: Familial Adenomatous Polyposis
Interventions: Drug: Eflornithine plus Sulindac;   Drug: Eflornithine and Placebo;   Drug: Sulindac and Placebo
17 Completed Single Incision Laparoscopic Surgery in Treating Patients With Colorectal Disease
Conditions: Adenomatous Polyp;   Crohn Disease;   Familial Adenomatous Polyposis;   Hereditary Intestinal Polyposis Syndrome;   Recurrent Colon Cancer;   Stage I Colon Cancer;   Stage IIA Colon Cancer;   Stage IIB Colon Cancer;   Stage IIC Colon Cancer;   Stage IIIA Colon Cancer;   Stage IIIB Colon Cancer;   Stage IIIC Colon Cancer
Intervention: Procedure: therapeutic laparoscopic surgery
18 Recruiting Curcumin in Treating Patients With Familial Adenomatous Polyposis
Condition: Familial Adenomatous Polyposis
Interventions: Other: placebo;   Other: laboratory biomarker analysis;   Drug: curcumin
19 Completed Is Diverting Ileostomy Necessary in Stapled Ileoanal Pouch?
Conditions: Ulcerative Colitis;   Familial Adenomatous Polyposis
Interventions: Procedure: adding diverting ileostomy;   Procedure: omitting diverting ileostomy
20 Withdrawn Use of Curcumin in the Lower Gastrointestinal Tract in Familial Adenomatous Polyposis Patients
Condition: Familial Adenomatous Polyposis
Intervention: Drug: curcumin

Previous Page Studies Shown (1-20) Next Page (21-31) Show next page of results
Indicates status has not been verified in more than two years